Celebrex patent expiration generic availability?

Short answer: yes—generic celecoxib (the generic for Celebrex) is available in the U.S. and most major markets, and the big patent on the celecoxib molecule has generally expired. Here are the key points:

- United States: The core celecoxib molecule patent expired in the U.S. around 2013–2014, and generic celecoxib tablets have been available since roughly 2014–2015. Today there are many generic manufacturers with multiple strengths/dosages.

- Europe and other markets: Generics for celecoxib are widely available in many countries. Exact timing varies by country due to regional patents, regulatory exclusivities, and secondary patents on formulations or uses.

- What can affect entry: Some patents on specific formulations or medical indications may still provide protection in certain jurisdictions, and regulatory exclusivities (e.g., pediatric exclusivity) can delay generic entry for particular uses. Authorized generics or settlement terms can also influence timing.

- How to check precisely: For the U.S., look up the FDA Orange Book entry for celecoxib to see current patent status and expiry dates. For Europe, check the EU or national patent registers and the EMA/European Medicines Agency listings. If you tell me your country (and the exact dose/form you care about), I can give a more precise status and point you to the exact patent/page.